Paul Debbage
- Pharmaceutical Science top 5%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 12
- Cancer Research top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 4
-
- MRI in cancer diagnosis 8
- Advanced MRI Techniques and Applications 6
-
- Glycosylation and Glycoproteins Research 9
- Angiogenesis and VEGF in Cancer 5
-
- Lanthanide and Transition Metal Complexes 8
-
- Barrier Structure and Function Studies 5
Paul Debbage
66 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 129
- Pharmaceutical Science 116
- Biomaterials 246
- Cancer Research 198
- Oncology 326
- Radiology, Nuclear Medicine and Imaging 261
Countries citing papers authored by Paul Debbage
This map shows the geographic impact of Paul Debbage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Debbage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Debbage more than expected).
Fields of papers citing papers by Paul Debbage
This network shows the impact of papers produced by Paul Debbage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Debbage. The network helps show where Paul Debbage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Debbage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2020 | 6 | |
| 3 | 2016 | 18 | |
| 4 | 2014 | 10 | |
| 5 | 2013 | 19 | |
| 6 | 2011 | 2 | |
| 7 | 2010 | 9 | |
| 8 | 2010 | 7 | |
| 9 | 2009 | 6 | |
| 10 | 2008 | 25 | |
| 11 | 2006 | 37 | |
| 12 | 2006 | 27 | |
| 13 | 2005 | 27 | |
| 14 | 2001 | 18 | |
| 15 | 2000 | 52 | |
| 16 | 1993 | 7 | |
| 17 | 1993 | 5 | |
| 18 | Lectin-binding sites in the retina of the pig, baboon and cat. | 1990 | 2 |
| 19 | 1989 | 13 | |
| 20 | 1988 | 27 |
About Paul Debbage
Paul Debbage is a scholar working on Biomaterials, Neurology, Radiology, Nuclear Medicine and Imaging, Developmental Neuroscience and Immunology and Allergy, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Glycosylation and Glycoproteins Research (9 papers), MRI in cancer diagnosis (8 papers), Lanthanide and Transition Metal Complexes (8 papers), Advanced MRI Techniques and Applications (6 papers), Angiogenesis and VEGF in Cancer (5 papers), Barrier Structure and Function Studies (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Pharmaceutical Science (116 citations), Biomaterials (246 citations), Cancer Research (198 citations), Oncology (326 citations) and Radiology, Nuclear Medicine and Imaging (261 citations). Paul Debbage has collaborated with scholars based in Austria, Germany and Egypt. Frequent co-authors include Werner Jaschke, Ira Skvortsova, Sergej Skvortsov, Peter Lukáš, Christian Kremser, Gudrun C. Thurner, Vinod Kumar, Peter Hutzler, Thomas Gneiting and Margit Pavelka. Their work appears in journals such as Histochemistry and Cell Biology, European Journal of Cancer, Molecular Imaging and Biology, Radiotherapy and Oncology and Seminars in Cancer Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.